BioNexus Gene Lab Corp.
NASDAQ: BGLC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Su-Leng Tan
- Employees
- 30
- Headquarters
- Kuala Lumpur, Malaysia
- IPO year
- 2021
- Market cap
- $4.2M
- Website
- https://www.bionexusgenelab.com
Loading BGLC…
Loading profile data…Frequently asked questions about BGLC
What does BioNexus Gene Lab Corp. (BGLC) do?
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asi...
Where does BGLC trade?
BioNexus Gene Lab Corp. (BGLC) trades on the NASDAQ Capital Market.
What sector is BGLC in?
BioNexus Gene Lab Corp. (BGLC) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of BioNexus Gene Lab Corp.?
Su-Leng Tan is the chief executive officer of BioNexus Gene Lab Corp. (BGLC).
Where is BioNexus Gene Lab Corp. headquartered?
BioNexus Gene Lab Corp. is headquartered in Malaysia.
Does BGLC pay a dividend?
BioNexus Gene Lab Corp. (BGLC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BGLC go public?
BioNexus Gene Lab Corp. (BGLC) completed its initial public offering in 2021.